Strategic Capital Advisers Inc. trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 7,466 shares of the medical equipment provider’s stock after selling 312 shares during the period. Intuitive Surgical makes up about 3.1% of Strategic Capital Advisers Inc.’s holdings, making the stock its 8th largest holding. Strategic Capital Advisers Inc.’s holdings in Intuitive Surgical were worth $4,285,000 as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of the stock. Adviser Investments LLC acquired a new position in Intuitive Surgical during the second quarter worth $115,000. Signet Financial Management LLC acquired a new position in Intuitive Surgical during the second quarter worth $115,000. Arrow Financial Corp acquired a new position in Intuitive Surgical during the third quarter worth $115,000. Optimum Investment Advisors lifted its stake in Intuitive Surgical by 189.9% during the third quarter. Optimum Investment Advisors now owns 229 shares of the medical equipment provider’s stock worth $131,000 after purchasing an additional 150 shares in the last quarter. Finally, Kaizen Advisory LLC raised its stake in shares of Intuitive Surgical by 156.0% in the second quarter. Kaizen Advisory LLC now owns 279 shares of the medical equipment provider’s stock valued at $133,000 after acquiring an additional 170 shares in the last quarter. Institutional investors own 84.14% of the company’s stock.
ISRG has been the topic of several analyst reports. Goldman Sachs Group increased their price objective on Intuitive Surgical from $540.00 to $630.00 and gave the company a “buy” rating in a research note on Friday, July 20th. Stifel Nicolaus increased their price objective on Intuitive Surgical from $515.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, July 20th. Cantor Fitzgerald reiterated a “buy” rating and issued a $620.00 price objective (up from $510.00) on shares of Intuitive Surgical in a research note on Friday, July 20th. Bank of America increased their price objective on Intuitive Surgical from $510.00 to $600.00 and gave the company a “buy” rating in a research note on Tuesday, July 17th. Finally, Citigroup increased their price objective on Intuitive Surgical from $561.00 to $592.00 and gave the company a “buy” rating in a research note on Thursday, August 2nd. One analyst has rated the stock with a sell rating, four have given a hold rating and seventeen have assigned a buy rating to the company. Intuitive Surgical has a consensus rating of “Buy” and an average price target of $554.01.
Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 18th. The medical equipment provider reported $2.83 EPS for the quarter, beating the consensus estimate of $2.66 by $0.17. The firm had revenue of $920.90 million for the quarter, compared to analyst estimates of $916.22 million. Intuitive Surgical had a return on equity of 18.79% and a net margin of 22.31%. Intuitive Surgical’s revenue for the quarter was up 14.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.77 earnings per share. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 9.52 EPS for the current fiscal year.
In related news, VP Jamie Samath sold 864 shares of the stock in a transaction on Tuesday, October 23rd. The stock was sold at an average price of $499.21, for a total value of $431,317.44. Following the transaction, the vice president now owns 257 shares of the company’s stock, valued at $128,296.97. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Mark J. Rubash sold 350 shares of the stock in a transaction on Friday, August 31st. The shares were sold at an average price of $560.00, for a total value of $196,000.00. Following the completion of the transaction, the director now directly owns 4,316 shares in the company, valued at approximately $2,416,960. The disclosure for this sale can be found here. Insiders sold 75,503 shares of company stock worth $38,771,530 in the last three months. 2.20% of the stock is currently owned by corporate insiders.
About Intuitive Surgical
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
See Also: Treasury Bonds
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.